21 related articles for article (PubMed ID: 21106240)
1. Profiling nuclear cysteine ligandability and effects on nuclear localization using proximity labeling-coupled chemoproteomics.
Peng Q; Weerapana E
Cell Chem Biol; 2024 Mar; 31(3):550-564.e9. PubMed ID: 38086369
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics Prediction and Machine Learning on Gene Expression Data Identifies Novel Gene Candidates in Gastric Cancer.
Kori M; Gov E
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553500
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia.
Guo H; Zhang TJ; Wen XM; Zhou JD; Ma JC; An C; Zhang W; Xu ZJ; Lin J; Qian J
Onco Targets Ther; 2017; 10():3635-3644. PubMed ID: 28790854
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and leukemia susceptibility in China: Evidence from an updated meta-analysis.
Jiang D; Li Y; Hong Q; Shen Y; Xu C; Xu Y; Zhu H; Dai D; Ouyang G; Duan S
Mol Clin Oncol; 2016 Sep; 5(3):193-207. PubMed ID: 27588182
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysis.
Jiang D; Hong Q; Shen Y; Xu Y; Zhu H; Li Y; Xu C; Ouyang G; Duan S
PLoS One; 2014; 9(5):e96822. PubMed ID: 24810788
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of CCAAT/enhancer binding protein zeta (C/EBPzeta) in patients with different myeloid diseases.
Qian J; Chen Z; Lin J; Wang W; Cen J
Leuk Res; 2005 Dec; 29(12):1435-41. PubMed ID: 16005964
[TBL] [Abstract][Full Text] [Related]
7. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia.
Xu Z; Wang M; Wang L; Wang Y; Zhao X; Rao Q; Wang J
Leuk Res; 2009 Jul; 33(7):891-7. PubMed ID: 19250671
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
Yao DM; Qian J; Lin J; Wang YL; Chen Q; Qian Z; Li Y; Wang CZ; Yang J
Leuk Res; 2011 Jul; 35(7):957-60. PubMed ID: 21106240
[TBL] [Abstract][Full Text] [Related]
12. Origins of aberrant DNA methylation in acute myeloid leukemia.
Schoofs T; Berdel WE; Müller-Tidow C
Leukemia; 2014 Jan; 28(1):1-14. PubMed ID: 23958917
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]